FMP
EURONEXT
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
5.1 EUR
0.8 (15.69%)
Mr. Stephane Ragusa
Healthcare
Medical - Diagnostics & Research
https://www.predilife.com
EURONEXT
Predilife S.A. develops and sells medical techniques and mathematical models. The company provides prevention and breast check-up tests. Its products include MammoRisk, a test for predicting the development of breast cancer based on the patient's individual risk; and DenSeeMammo, a breast density measurement software, as well as a medical device for the prediction of prostate cancer risk. Predilife S.A. was founded in 2004 and is headquartered in Villejuif, France.
N/A
FR0010169920
F8580W104
39, Rue Camille Desmoulins
33 9 53 75 85 43
FR
20
Dec 21, 2018
-
EURONEXT
Medical - Diagnostic...
Healthcare
F8580W104
FR0010169920
FR
5.1
0.23
1.1k
18.9M
-
3.6-6.8
0
-
-
-
-
-4.72
-
https://www.predilife.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.